Swirsky Douglas J
- SEC CIK
- 0001375884
In the past year, 1 open-market sale filing worth $8.32K and no purchases.
Current role at each company
- CLRB Cellectar Biosciences, Inc.Directoras of Jul 8, 2026
- MXCT Maxcyte, Inc.CHIEF FINANCIAL OFFICERas of Mar 19, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $8.32K
- 1 filing
- Net
- −$8.32K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Swirsky Douglas J as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
MXCT Maxcyte, Inc.
CHIEF FINANCIAL OFFICER3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 19, 2026 (view filing) | Mar 17 | 2 days | Swirsky Douglas JCHIEF FINANCIAL OFFICER | SSale | −10.1K | $0.82 | −$8.32K | −6.3%151.7K after | |
| Aug 13, 2025 (view filing) | Aug 13 | Same day | Swirsky Douglas JCHIEF FINANCIAL OFFICER | PPurchase | +50.0K | $1.29 | +$64.5K | +44.7%161.8K after | |
| Mar 20, 2025 (view filing) | Mar 18 | 2 days | Swirsky Douglas JCHIEF FINANCIAL OFFICER | SSale | −6.94K | $3.18 | −$22.1K | −5.8%111.8K after |
CLRB Cellectar Biosciences, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 14, 2021 (view filing) | Sep 14 | Same day | Swirsky Douglas JDirector | PPurchase | +25.0K | $1.04 | +$26.0K | New position25.0K after |